Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Remnant cholesterol and residual cardiovascular risk in diabetic patients undergoing coronary revascularization: insights from a nationwide ohort

Remnant cholesterol (remnant-C) is an emerging contributor to residual cardiovascular risk, particularly in patients with diabetes mellitus (DM). To evaluate the prognostic impact of remnant-C levels in diabetic patients who underwent percutaneous coronary intervention (PCI) or coronary artery bypass graft...

H. Jeon, H. Kim, S. Kim et al. · 0 citations
Review Aug 2026

Discontinuation of β-blockers in stable patients with previous myocardial infarction, preserved left ventricular ejection fraction, and no heart failure: a pooled analysis of individual patient data.

In stable patients with previous myocardial infarction, left ventricular ejection fraction ≥40%, no heart failure, and no other indication for β-blocker therapy, discontinuation met the non-inferiority criteria for the primary and key secondary endpoints.

J. Silvain, Ki H. Choi, Victorien Monguillon et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.